chr22-37759212-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001039141.3(TRIOBP):āc.6272G>Cā(p.Ser2091Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000773 in 1,613,080 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001039141.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIOBP | NM_001039141.3 | c.6272G>C | p.Ser2091Thr | missense_variant | 17/24 | ENST00000644935.1 | NP_001034230.1 | |
TRIOBP | NM_007032.5 | c.1133G>C | p.Ser378Thr | missense_variant | 7/14 | NP_008963.3 | ||
TRIOBP | NM_138632.2 | c.1133G>C | p.Ser378Thr | missense_variant | 7/8 | NP_619538.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIOBP | ENST00000644935.1 | c.6272G>C | p.Ser2091Thr | missense_variant | 17/24 | NM_001039141.3 | ENSP00000496394.1 |
Frequencies
GnomAD3 genomes AF: 0.00396 AC: 603AN: 152100Hom.: 6 Cov.: 31
GnomAD3 exomes AF: 0.000884 AC: 220AN: 248942Hom.: 2 AF XY: 0.000658 AC XY: 89AN XY: 135174
GnomAD4 exome AF: 0.000439 AC: 642AN: 1460860Hom.: 8 Cov.: 31 AF XY: 0.000383 AC XY: 278AN XY: 726748
GnomAD4 genome AF: 0.00397 AC: 605AN: 152220Hom.: 6 Cov.: 31 AF XY: 0.00406 AC XY: 302AN XY: 74444
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 07, 2012 | Ser2091Thr in Exon 17 of TRIOBP: This variant is not expected to have clinical s ignificance because it has been identified in 1.3% (50/3732) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs78758968). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at